Inhaled Zanamivir for the Prevention of Influenza in Families

2000374 citationsJournal Articlebronze Open Access

Authors

Frederick G. Hayden · University of Virginia

Larisa V. Gubareva · University of Virginia

Arnold S. Monto · University of Michigan–Ann Arbor

Thomas Klein

Michael J. Elliott

Janet Hammond

Stephen J. Sharp · Wellcome Library

M J Ossi

Abstract

When combined with the treatment of index cases, prophylactic treatment of family members with once-daily inhaled zanamivir is well tolerated and prevents the development of influenza. In this study there was no evidence of the emergence of resistant influenza variants.

Topics & Keywords

Pneumocystis jirovecii pneumonia detection and treatment Synthesis and Biological Evaluation Influenza Virus Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 343, Issue 18, pp. 1282-1289

DOI: 10.1056/nejm200011023431801

Field-Weighted Citation Impact: 26.40